BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 20357199)

  • 1. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
    Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.
    Pease ME; McKinnon SJ; Quigley HA; Kerrigan-Baumrind LA; Zack DJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):764-74. PubMed ID: 10711692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.
    Fu QL; Li X; Yip HK; Shao Z; Wu W; Mi S; So KF
    Neuroscience; 2009 Aug; 162(2):375-82. PubMed ID: 19422885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enriched environment during adolescence changes brain-derived neurotrophic factor and TrkB levels in the rat visual system but does not offer neuroprotection to retinal ganglion cells following axotomy.
    Franklin TB; Murphy JA; Myers TL; Clarke DB; Currie RW
    Brain Res; 2006 Jun; 1095(1):1-11. PubMed ID: 16730677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in brain-derived neurotrophic factor and trkB receptor in the adult Rana pipiens retina and optic tectum after optic nerve injury.
    Duprey-Díaz MV; Soto I; Blagburn JM; Blanco RE
    J Comp Neurol; 2002 Dec; 454(4):456-69. PubMed ID: 12455009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
    Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma.
    Iwabe S; Moreno-Mendoza NA; Trigo-Tavera F; Crowder C; García-Sánchez GA
    Vet Ophthalmol; 2007; 10 Suppl 1():12-9. PubMed ID: 17973830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension.
    Rudzinski M; Wong TP; Saragovi HU
    J Neurobiol; 2004 Feb; 58(3):341-54. PubMed ID: 14750147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different optic nerve injury sites result in different responses of retinal ganglion cells to brain-derived neurotrophic factor but not neurotrophin-4/5.
    Zhi Y; Lu Q; Zhang CW; Yip HK; So KF; Cui Q
    Brain Res; 2005 Jun; 1047(2):224-32. PubMed ID: 15904902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of trkA, trkB, and trkC in injured and regenerating retinal ganglion cells of adult rats.
    Cui Q; Tang LS; Hu B; So KF; Yip HK
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1954-64. PubMed ID: 12037005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells.
    Hu Y; Cho S; Goldberg JL
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1747-54. PubMed ID: 19875669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture.
    Fischer D; Pavlidis M; Thanos S
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3943-54. PubMed ID: 11053298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo.
    Shi Z; Birman E; Saragovi HU
    Dev Neurobiol; 2007 Jun; 67(7):884-94. PubMed ID: 17506493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo.
    Pernet V; Di Polo A
    Brain; 2006 Apr; 129(Pt 4):1014-26. PubMed ID: 16418178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat.
    Lau J; Dang M; Hockmann K; Ball AK
    Exp Eye Res; 2006 Jan; 82(1):132-45. PubMed ID: 16045909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model.
    Swanson KI; Schlieve CR; Lieven CJ; Levin LA
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3737-41. PubMed ID: 16186357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.
    Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):975-85. PubMed ID: 18326721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions.
    Huang Y; Cen LP; Choy KW; van Rooijen N; Wang N; Pang CP; Cui Q
    Exp Eye Res; 2007 Nov; 85(5):684-95. PubMed ID: 17869246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.